the staff of the Ridgewood blog
A new blood test is showing “high accuracy” in screening for Alzheimer’s Disease markers, before the onset of symptoms according to a study published in JAMA Neurology this week. The study involved testing blood for a key biomarker of Alzheimer’s, a protein called phosphorylated tau or p-tau21, which increases at the same time as other damaging proteins — beta amyloid and tau — build up in the brains of people with the disease.
